Delivery Order SPE2DB20D3103-SPE2DB22FN0S3
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of Loteprednol 0.5% ophthalmic gel 5GM. The contract has a ceiling value of $1,848.57 and a completion date of September 28, 2023. This is a Firm Fixed Price Delivery Order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.23 delivery order contract is for the supply of the pharmaceutical product Loteprednol Etabonate 0.5% Ophthalmic Drops, 5 ML. The contract is not designated as a set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of loteprednol 0.5% ophthalmic gel, a prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,645.18 and a completion date of July 15, 2024. The contract is a delivery order placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award, valued at $2,463.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LOTEPREDNOL DROPS 1S, a pharmaceutical product, with a period of performance through March 22, 2024. This award is not designated as a set-aside contract. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.82 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% ophthalmic drops (5ml). The contract was awarded on September 7, 2021, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,324.32 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% Eye Drops, 15 ml, with a performance period ending on February 1, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,631.68 delivery order contract is for the supply of Loteprednol Etabonate 0.5% eye drops, a pharmaceutical product. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,405.28 firm-fixed-price delivery order is for the supply of 4558884048 - Loteprednol Etabonate 0.5% Eye Drops in 5 mL containers. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award, valued at $1,721.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of Loteprednol Etabonate 0.5% DRP 5ML, a prescription medication. The contract has an ultimate completion date of July 3, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
- This federal contract award, valued at $1,097.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical eye drop product. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN0S3Delivery Order
This federal contract award, valued at $1,557.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order for the pharmaceutical product Loteprednol 0.5% Ophthalmic Gel, 5 gm. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is issued under that overarching IDC contract. Amerisourcebergen Drug Corp also maintains a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/21/22 |